Swiss court reaffirms recommended retail price ruling
Switzerland’s highest court has once again ruled that recommended price-list publications are anticompetitive, ordering a lower court to confirm sanctions against Eli Lilly and Bayer for restricting competition for their respective erectile dysfunction drugs.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.